KITHER BIOTECH S R L has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are DCB-USA LLC, MAGENTA THERAPEUTICS INC and INTREXON ACTOBIOTICS N V.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Hungary | 1 | |
#8 | Israel | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hirsch Emilio | 10 |
#2 | Ghigo Alessandra | 9 |
#3 | Tron Gian Cesare | 1 |
#4 | Alessandra Ghigo | 1 |
#5 | Ciraolo Elisa | 1 |
#6 | Galli Ubaldina | 1 |
#7 | Massarotti Alberto | 1 |
#8 | Emilio Hirsch | 1 |
#9 | Pirali Tracey | 1 |
#10 | Sorba Giovanni | 1 |
Publication | Filing date | Title |
---|---|---|
CN107406488A | For treating the new PI3K gamma inhibitors peptide of respiratory disease |